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Purpose: Monte Carlo (MC) codes are widely used in the 
hadrontherapy community due to their detailed description 
of radiation transport and interaction with matter. In this 
work, we present the latest developments and applications 
of the FLUKA Monte Carlo code [1,2].   
Material/methods: MC methods are being utilized at several 
institutions for a wide range of activities spanning from beam 
characterization to quality assurance and 
dosimetric/radiobiological studies. The suitability of a MC 
code for application to hadrontherapy demands accurate and 
reliable physical models for the description of the transport 
and the interaction of all components of the expected 
radiation field. This becomes extremely important to 
correctly perform not only physical but also biological dose 
calculations. In addition, accurate prediction of emerging 
secondary radiation is of utmost importance in emerging 
areas of research aiming at in-vivo treatment verification.  
Results: Validations and applications at several experimental 
sites as well as proton/ion therapy facilities with active beam 
delivery systems will be presented:  
• Physical database generation: laterally integrated 
depth-dose profiles, lateral-dose distributions at 
different depths, secondary fragment yields and 
fragment energy spectra at different depths.  
• Forward MC re-calculations of physical/RBE-
weighted dose distributions of proton and carbon 
ion treatment plans.  
• MC-based treatment planning for proton and heavy 
ions beam therapy. 
• Studies for introducing new ions (4He and 16O) in 
the clinical practice.  
Conclusions: FLUKA's flexibility and the satisfactory 
agreements with several dosimetric data and nuclear 
fragment yields demonstrate that the code is a valuable and 
powerful support for the hadrontherapy community.  
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Purpose: Conventionally, intensity modulated particle 
therapy (IMPT) fields are optimized independently of the 
fractionation scheme. Following some precursory works [1—
3], this study aims at investigating whether the application of 
spatial and temporal modulations in fractionation patterns, 
which involve the delivery of daily inhomogeneous fractional 
dose (IFD) distributions, may increase the therapeutic gain. 
Materials/Methods: We simulated the irradiation of different 
clinical cases with different ions (1H, 4He, 12C) and we carried 
out a comparison between two types of treatment plans. 
These were: (1) a conventional plan with a standard 
fractionation scheme in which each beam irradiates the 
whole planning target volume (PTV) delivering a uniform dose 
of 2 Gy per fraction; (2) an alternative plan that implies IFD 
distributions, delivering homogeneous dose to distinct regions 
of the PTV in different fractions. Each field was weighted to 
minimize its contribution to the proximal region of the PTV, 
so to limit the dose excursion in the surrounding normal 
tissues and obtain different local fractionation schemes in 
the volumes of interest. The comparison was based on the 
evaluation of the tumor complication probability (TCP) and 
normal tissue complication probability (NTCP). We evaluated 
these quantities following the approach proposed by Kallman 
et al. [4], based on the Linear-Quadratic-Poisson model. We 
considered a variable relative biological effectiveness (RBE) 
and the impact of the variable linear energy transfer (LET) 
distributions on the sensitivity to the time structure of the 
irradiation. 
Results: For the considered cases, the comparison showed 
that the IFD-based approach leads to an improvement of the 
therapeutic index with respect to the standard approach (+6-
10%). The extent of the gain is dependent, among other 
factors, on the sensitivity of the tissues to the employed ion 
radiation. Some critical issues were identified related to the 
choice of weights and spatial configurations of the fields. 
Conclusions: This work investigates the possibility to improve 
the therapeutic index by delivering temporally and spatially 
heterogeneous dose distributions in the PTV, following the 
IFD paradigm. A methodology has been found which has 
proven to be successful in the considered clinical cases. 
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In Particle Therapy, cancer treatments are performed using 
accelerated charged particles whose high irradiation 
precision and conformity allows the tumor destruction while 
sparing the surrounding healthy tissues. Dose release 
monitoring devices using photons and charged particles 
produced by the beam interaction with the patient body have 
already been proposed, but no attempt based on the 
detection of the abundant secondary radiation neutron 
component has been made yet. The reduced attenuation 
length of neutrons yields a secondary particle sample that is 
larger in number when compared to photons and charged 
particles. Furthermore, neutrons allow for a backtracking of 
the emission point that is not affected by multiple scattering. 
Since neutrons can release a significant dose far away from 
the tumor region, a precise measurement of their flux, 
production energy and angle distributions is eagerly needed 
